Supplemental material
Gynecological Endocrinology
Volume 39, 2023 - Issue 1
Open access
1,387
Views
1
CrossRef citations to date
0
Altmetric
Research Article
Relugolix combination therapy in European women with symptomatic uterine fibroids: a subgroup analysis from the randomized phase 3 LIBERTY pivotal trials
Roberta Venturellaa Department of Clinical and Experimental Medicine, Unit of Obstetrics and Gynecology, Magna Graecia University of Catanzaro, Catanzaro, ItalyCorrespondence[email protected]
https://orcid.org/0000-0003-1359-770XView further author information
, https://orcid.org/0000-0003-1359-770XView further author information
Tomasz Rechbergerb Second Department of Gynecology, Medical University of Lublin, Lublin, Polandhttps://orcid.org/0000-0003-4138-332XView further author information
, János Zatikc Szent Anna Women’s OB/GYN and Ultrasound Outpatient Clinic, Debrecen, HungaryView further author information
, Rachel B. Wagmand Clinical Research, Sumitomo Pharma America, Inc., Brisbane, CA, USAView further author information
, Emily Zhue Development Operation, Sumitomo Pharma America, Inc., Brisbane, CA, USAView further author information
, Viatcheslav G. Rakovf Research and Development, Myovant Sciences GmbH, Basel, Switzerlandhttps://orcid.org/0009-0004-0324-9239View further author information
& Felice Petragliag Department of Experimental, Clinical and Biomedical Sciences, Obstetrics and Gynecology, University of Florence, Careggi University Hospital, Florence, Italyhttps://orcid.org/0000-0002-8851-625XView further author information
show all
Article: 2249107
|
Received 24 Jan 2023, Accepted 09 Aug 2023, Published online: 27 Aug 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.